On 22 March 2019, the Global Fund Board approved funding for two country grants and supplementary funding for a third –– for a total value of $11.0 million. Interventions worth $4.1 million were added to the Unfunded Quality Demand (UQD) Register. Domestic commitments for the programs included in the approved country grants amounted to $28.5 million. (See Table 1 for details.)
An investigation by the Office of the Inspector General into an HIV grant to Egypt has found evidence of fraudulent practices and other procurement irregularities on the part of the principal recipient, the National AIDS Program, which compromised contracts worth $668,877.
The Global Fund has brokered debt swap agreement before, but not like the latest one between Germany and Egypt.
The Global Fund Board has approved two of the twelve Round 6 proposals whose original rejection had been appealed by the applicants. The newly approved proposals are an HIV/AIDS proposal from Egypt that will cost $5.4 million over the first two years, and a TB proposal from Pakistan that will cost $22.6 million. The approvals are subject to a number of clarifications being successfully responded to in a timely manner.